.
MergerLinks Header Logo

New Deal


Announced

Astorg Partners to acquire Demetra Holding from Keensight Capital.

Financials

Edit Data
Transaction Value-
Consideration TypeCash
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

Single Bidder

Disposal

Majority

orthopaedic biomaterials

bone cement

Pending

Private

Friendly

Biotechnology

Italy

Private Equity

Acquisition

Cross Border

Synopsis

Edit

Astorg Partners, a private equity firm, agreed to acquire Demetra Holding, a biomaterials company, from Keensight Capital, a private equity firm. Financial terms were not disclosed. “Demetra is another illustration of a Keensight-backed success story in Healthcare, transforming a small European company into a global leader. Our track-record with Demetra reflects our investment strategy in fast-growing and profitable companies, as well as our capacity to create value through international expansion. We would like to thank Denis Faccioli and Massimo Grazioli for this amazing journey together. We wish them all the best as they continue their great story," Pierre Rémy, Keensight Capital Managing Partner.

Search a database of more than 250,000 verified dealmakers

Receive automated updates on global transactions

Follow the activity, relationships and transactions of top dealmakers

No credit card required

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US